Moderna’s reformulated mRNA COVID injection, the highly touted — and continuously delayed — “Omicron vaccine,” was tailored to an Omicron subvariant that no longer exists.
The pharmaceutical company’s Omicron-specific shot was formulated for the BA.1 subvariant of Omicron, which hasn’t been identified in genomic surveillance for several months.
The Dossier is a reader-supported publication. To receive new posts and support my work, consider becoming a subscriber.
Here’s the data directly from the CDC’s genomic surveillance tracker : As you can see, BA. 1 is now registering at 0%, and it has been superseded by several newer variants. Moderna seeking FDA authorization of omicron-specific booster shot Moderna released a press release Wednesday touting its Omicron injection, but admitted that the “ shot elicited a weaker response versus BA.4 and BA.5 ,” according to Reuters. Moreover, the shot has not even been tested on the latest subvariant, BA 2.12.1.The Massachusetts-based biotech company drove tons […]
Excerpt Sourced From: dossier.substack.com
